Skip to content
2000
image of Transcending Cellular Barriers by Leveraging Nano-Bio Interactions in Nanomaterial-Driven Disease Therapy

Abstract

Nanomedicine, a fusion of science and technology, involves the design and development of nanosystems at the forefront of biomedical innovation. These systems, engineered at molecular, atomic, and macromolecular sizes, generate minuscule particles with distinctive features. Nanomedicines and nano-drug delivery systems determine their biological destiny using size, surface characteristics, and composition. The primary objective is focused intervention; however, the plasma membrane presents a barrier that restricts the entry of therapeutic substances into cells, hence diminishing their efficacy. Numerous pharmacological drugs attempt to modulate intracellular components, yet their permeability across cellular membranes frequently remains insufficient. Understanding the interactions between cells and nanomaterials is thus essential. A systematic literature search using PubMed, Web of Science, and Google Scholar databases was conducted to identify recent, high-impact studies emphasizing the translational potential of nanomedicine. The search prioritized articles on nanomaterial properties, cellular uptake mechanisms, and disease-specific applications. The complex cellular uptake processes have been found to involve a refined interaction with cell membranes, incorporating mechanisms, like endocytosis and phagocytosis. However, custom nanomaterial designs are essential because cells involved in photothermal treatment could have different mechanisms for absorption. Comprehending intracellular pathways is essential to enhance the targeting of therapeutic and imaging agents. From the perspective of several physicochemical attributes, this review addresses biocompatibility and possible nanotoxicity within biological systems and their likely utility for site-specific targeting, delivering more significant therapeutic effects for disease therapy.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ctmc/10.2174/0115680266362334251024043000
2026-03-04
2026-03-08

  • From This Site

    /content/journals/ctmc/10.2174/0115680266362334251024043000
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Ma N. Ma C. Li C. Wang T. Tang Y. Wang H. Mou X. Chen Z. He N. Influence of nanoparticle shape, size, and surface functionalization on cellular uptake. J. Nanosci. Nanotechnol. 2013 13 10 6485 6498 10.1166/jnn.2013.7525 24245105
    [Google Scholar]
  2. Tripathi D. Srivastava M. Rathour K. Rai A.K. Wal P. Sahoo J. Tiwari R.K. Pandey P. A promising approach of dermal targeting of antipsoriatic drugs via engineered nanocarriers drug delivery systems for tackling psoriasis. Drug Metab. Bioanal Lett 2023 16 2 89 104 10.2174/2949681016666230803150329 37534794
    [Google Scholar]
  3. Takahashi K. Ochi A. Mihara H. Ogra Y. Comparison of nutritional availability of biogenic selenium nanoparticles and chemically synthesized selenium nanoparticles. Biol. Trace Elem. Res. 2023 201 10 4861 4869 10.1007/s12011‑023‑03567‑6 36648599
    [Google Scholar]
  4. Tripathi D. Pandey P. Sharma S. Rai A.K. Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity. Bioimpacts 2024 15 30573 30573 10.34172/bi.30573
    [Google Scholar]
  5. Nakkina VNL Nagumantri HT Degala RP Recent advances in nanomedicine. J. Pharm. Insights Res. 2025, 3, 073-083
    [Google Scholar]
  6. Sahu T. Ratre Y.K. Chauhan S. Bhaskar L.V.K.S. Nair M.P. Verma H.K. Nanotechnology based drug delivery system: Current strategies and emerging therapeutic potential for medical science. J. Drug Deliv. Sci. Technol. 2021 63 102487 10.1016/j.jddst.2021.102487
    [Google Scholar]
  7. Aengenheister L. Favaro R.R. Morales-Prieto D.M. Furer L.A. Gruber M. Wadsack C. Markert U.R. Buerki-Thurnherr T. Research on nanoparticles in human perfused placenta: State of the art and perspectives. Placenta 2021 104 199 207 10.1016/j.placenta.2020.12.014 33418345
    [Google Scholar]
  8. Liddle J.A. Gallatin G.M. Nanomanufacturing: A perspective. ACS Nano 2016 10 3 2995 3014 10.1021/acsnano.5b03299 26862780
    [Google Scholar]
  9. Deepak P. Kumar P. Pandey P. Arya D.K. Jaiswal S. Kumar A. Sonkar A.B. Ali D. Alarifi S. Ramar M. Rajinikanth P.S. Pentapeptide cRGDfK-surface engineered nanostructured lipid carriers as an efficient tool for targeted delivery of tyrosine kinase inhibitor for battling hepatocellular carcinoma. Int. J. Nanomedicine 2023 18 7021 7046 10.2147/IJN.S438307 38046236
    [Google Scholar]
  10. Gupta P.C. Kapoor A. Pandey P. Designing and characterization of econazole nitrate nanostructured lipid carriers gel for topical delivery. Eur. J. Pharm. Med. Res. 2018 5 559 567
    [Google Scholar]
  11. Le D. Keller D. Delaittre G. Reactive and functional nanoobjects by polymerization‐induced self‐assembly. Macromol. Rapid Commun. 2019 40 2 1800551 10.1002/marc.201800551 30325550
    [Google Scholar]
  12. Panda S. Hajra S. Kaushik A. Rubahn H.G. Mishra Y.K. Kim H.J. Smart nanomaterials as the foundation of a combination approach for efficient cancer theranostics. Mater. Today Chem. 2022 26 101182 10.1016/j.mtchem.2022.101182
    [Google Scholar]
  13. Saravanakumar K. Hu X. Ali D.M. Wang M.H. Emerging strategies in stimuli-responsive nanocarriers as the drug delivery system for enhanced cancer therapy. Curr. Pharm. Des. 2019 25 24 2609 2625 10.2174/1381612825666190709221141 31603055
    [Google Scholar]
  14. Pandey P. Gupta, PC Solid lipid nanoparticles: A potential approach in drug delivery system. Eur. J. Pharm. Sci. 2018 5 9 225 236
    [Google Scholar]
  15. Abid N. Khan A.M. Shujait S. Chaudhary K. Ikram M. Imran M. Haider J. Khan M. Khan Q. Maqbool M. Synthesis of nanomaterials using various top-down and bottom-up approaches, influencing factors, advantages, and disadvantages: A review. Adv. Colloid Interface Sci. 2022 300 102597 10.1016/j.cis.2021.102597 34979471
    [Google Scholar]
  16. Arole V. Munde S. Fabrication of nanomaterials by top-down and bottom-up approaches-an overview. J. Mater. Sci. 2014 1 89 93
    [Google Scholar]
  17. Chen F. Yan T-H. Bashir S. Liu J.L. Synthesis of nanomaterials using top-down methods. Advanced Nanomaterials and Their Applications in Renewable Energy. Elsevier 2022 37 60 10.1016/B978‑0‑323‑99877‑2.00007‑2
    [Google Scholar]
  18. Fratila R.M. Rivera-Fernández S. de la Fuente J.M. Shape matters: Synthesis and biomedical applications of high aspect ratio magnetic nanomaterials. Nanoscale 2015 7 18 8233 8260 10.1039/C5NR01100K 25877250
    [Google Scholar]
  19. Baig N. Kammakakam I. Falath W. Nanomaterials: A review of synthesis methods, properties, recent progress, and challenges. Materials Advances 2021 2 6 1821 1871 10.1039/D0MA00807A
    [Google Scholar]
  20. Ali A. Shah T. Ullah R. Zhou P. Guo M. Ovais M. Tan Z. Rui Y. Review on recent progress in magnetic nanoparticles: Synthesis, characterization, and diverse applications. Front Chem. 2021 9 629054 10.3389/fchem.2021.629054 34327190
    [Google Scholar]
  21. Tomar R. Abdala A.A. Chaudhary R.G. Singh N.B. Photocatalytic degradation of dyes by nanomaterials. Mater. Today Proc. 2020 29 967 973 10.1016/j.matpr.2020.04.144
    [Google Scholar]
  22. Kamanina N. Nanotechnology in optics. CBU International Conference Proceedings September 2018 1114 1120
    [Google Scholar]
  23. Tiwari A.K. Pandey P.C. Gupta M.K. Narayan R.J. Nano–bio interaction and antibacterial mechanism of engineered metal nanoparticles: Fundamentals and current understanding. J. Cluster Sci. 2025 36 1 5 10.1007/s10876‑024‑02728‑4
    [Google Scholar]
  24. Khan I. Saeed K. Khan I. Nanoparticles: Properties, applications and toxicities. Arab. J. Chem. 2019 12 7 908 931 10.1016/j.arabjc.2017.05.011
    [Google Scholar]
  25. Kumari S. Raturi S. Kulshrestha S. Chauhan K. Dhingra S. András K. Thu K. Khargotra R. Singh T. A comprehensive review on various techniques used for synthesizing nanoparticles. J. Mater. Res. Technol. 2023 27 1739 1763 10.1016/j.jmrt.2023.09.291
    [Google Scholar]
  26. Wu Q. Miao W. Zhang Y. Gao H. Hui D. Mechanical properties of nanomaterials: A review. Nanotechnol. Rev. 2020 9 1 259 273 10.1515/ntrev‑2020‑0021
    [Google Scholar]
  27. Skomski R. Balasubramanian B. Sellmyer D.J. Magnetism of nanomaterials. In: Magnetic Nanomaterials: Fundamentals, Synthesis and Applications. Wiley 2017 29 80 10.1002/9783527803255.ch2
    [Google Scholar]
  28. Ghosh C.K. Quantum effect on properties of nanomaterials. In: Introduction to nano: Basics to nanoscience and nanotechnology. Springer 2015 73 111 10.1007/978‑3‑662‑47314‑6_5
    [Google Scholar]
  29. Coetzee D. Venkataraman M. Militky J. Petru M. Influence of nanoparticles on thermal and electrical conductivity of composites. Polymers 2020 12 4 742 10.3390/polym12040742 32230802
    [Google Scholar]
  30. Reghunadhan A. Kalarikkal N. Thomas S. Mechanical property analysis of nanomaterials. Characterization of Nanomaterials. Elsevier 2018 191 212
    [Google Scholar]
  31. Wang J. Gu H. Novel metal nanomaterials and their catalytic applications. Molecules 2015 20 9 17070 17092 10.3390/molecules200917070 26393550
    [Google Scholar]
  32. Díez-Pascual A. Recent progress in antimicrobial nanomaterials. Nanomaterials 2020 10 11 2315 10.3390/nano10112315 33238368
    [Google Scholar]
  33. Huang X. El-Sayed M.A. Gold nanoparticles: Optical properties and implementations in cancer diagnosis and photothermal therapy. J. Adv. Res. 2010 1 1 13 28 10.1016/j.jare.2010.02.002
    [Google Scholar]
  34. Ju Y. Guo H. Edman M. Hamm-Alvarez S.F. Application of advances in endocytosis and membrane trafficking to drug delivery. Adv. Drug Deliv. Rev. 2020 157 118 141 10.1016/j.addr.2020.07.026 32758615
    [Google Scholar]
  35. Arias L.S. Pessan J.P. Vieira A.P.M. Lima T.M.T. Delbem A.C.B. Monteiro D.R. Iron oxide nanoparticles for biomedical applications: A perspective on synthesis, drugs, antimicrobial activity, and toxicity. Antibiotics 2018 7 2 46 10.3390/antibiotics7020046 29890753
    [Google Scholar]
  36. Augustine R. Hasan A. Emerging applications of biocompatible phytosynthesized metal/metal oxide nanoparticles in healthcare. J. Drug Deliv. Sci. Technol. 2020 56 101516 10.1016/j.jddst.2020.101516
    [Google Scholar]
  37. Kyriakides T.R. Raj A. Tseng T.H. Xiao H. Nguyen R. Mohammed F.S. Halder S. Xu M. Wu M.J. Bao S. Sheu W.C. Biocompatibility of nanomaterials and their immunological properties. Biomed. Mater. 2021 16 4 042005 10.1088/1748‑605X/abe5fa 33578402
    [Google Scholar]
  38. Neha Desai, Momin, M.; Khan, T.; Gharat, S.; Ningthoujam, R.S.; Omri, A. Metallic nanoparticles as drug delivery system for the treatment of cancer. Expert Opin. Drug Deliv. 2021 18 9 1261 1290 10.1080/17425247.2021.1912008 33793359
    [Google Scholar]
  39. Khalid K. Tan X. Mohd Zaid H.F. Tao Y. Lye Chew C. Chu D.T. Lam M.K. Ho Y.C. Lim J.W. Wei C. L. Advanced in developmental organic and inorganic nanomaterial: A review. Bioengineered 2020 11 1 328 355 10.1080/21655979.2020.1736240 32138595
    [Google Scholar]
  40. Chen Y. Li L. Gong L. Zhou T. Liu J. Surface regulation towards stimuli‐responsive luminescence of ultrasmall thiolated gold nanoparticles for ratiometric imaging. Adv. Funct. Mater. 2019 29 10 1806945 10.1002/adfm.201806945
    [Google Scholar]
  41. Septiadi D. Crippa F. Moore T.L. Rothen-Rutishauser B. Petri-Fink A. Nanoparticle–cell interaction: A cell mechanics perspective. Adv. Mater. 2018 30 19 1704463 10.1002/adma.201704463 29315860
    [Google Scholar]
  42. Ahmed B.S. Baijal G. Somashekar R. Iyer S. Nayak V. Comparative study of one pot synthesis of PEGylated gold and silver nanoparticles for imaging and radiosensitization of oral cancers. Radiat. Phys. Chem. 2022 194 109990 10.1016/j.radphyschem.2022.109990
    [Google Scholar]
  43. Niculescu A.G. Grumezescu A.M. Applications of chitosan-alginate-based nanoparticles—An up-to-date review. Nanomaterials 2022 12 2 186 10.3390/nano12020186 35055206
    [Google Scholar]
  44. Alshamrani M. Broad-spectrum theranostics and biomedical application of functionalized nanomaterials. Polymers 2022 14 6 1221 10.3390/polym14061221 35335551
    [Google Scholar]
  45. Mala R. Celsia A. Toxicity of nanomaterials to biomedical applications— A review. Fundamental Biomaterials. Ceramics 2018 439 473
    [Google Scholar]
  46. Schäffler M. Sousa F. Wenk A. Sitia L. Hirn S. Schleh C. Haberl N. Violatto M. Canovi M. Andreozzi P. Salmona M. Bigini P. Kreyling W.G. Krol S. Blood protein coating of gold nanoparticles as potential tool for organ targeting. Biomaterials 2014 35 10 3455 3466 10.1016/j.biomaterials.2013.12.100 24461938
    [Google Scholar]
  47. Finbloom J.A. Sousa F. Stevens M.M. Desai T.A. Engineering the drug carrier biointerface to overcome biological barriers to drug delivery. Adv. Drug Deliv. Rev. 2020 167 89 108 10.1016/j.addr.2020.06.007 32535139
    [Google Scholar]
  48. Blanco E. Shen H. Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 2015 33 9 941 951 10.1038/nbt.3330 26348965
    [Google Scholar]
  49. Cuggino J.C. Blanco E.R.O. Gugliotta L.M. Alvarez Igarzabal C.I. Calderón M. Crossing biological barriers with nanogels to improve drug delivery performance. J. Control. Release 2019 307 221 246 10.1016/j.jconrel.2019.06.005 31175895
    [Google Scholar]
  50. Fuster J.J. Ouchi N. Gokce N. Walsh K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ. Res. 2016 118 11 1786 1807 10.1161/CIRCRESAHA.115.306885 27230642
    [Google Scholar]
  51. Oliva N. Carcole M. Beckerman M. Seliktar S. Hayward A. Stanley J. Parry N.M.A. Edelman E.R. Artzi, N Regulation of dendrimer/dextran material performance by altered tissue microenvironment in inflammation and neoplasia. Sci. Transl. Med. 2015 7 272ra11
    [Google Scholar]
  52. Chede S.A. Fouling control using temperature responsive membranes composed of N-isopropylacrylamide (NIPAAm) and iron oxide nanoparticles. University of Toledo 2015
    [Google Scholar]
  53. Li H. Jin K. Luo M. Wang X. Zhu X. Liu X. Jiang T. Zhang Q. Wang S. Pang Z. Size dependency of circulation and biodistribution of biomimetic nanoparticles: Red blood cell membrane-coated nanoparticles. Cells 2019 8 8 881 10.3390/cells8080881 31412631
    [Google Scholar]
  54. Moraru C. Mincea M. Menghiu G. Ostafe V. Understanding the factors influencing chitosan-based nanoparticles-protein corona interaction and drug delivery applications. Molecules 2020 25 20 4758 10.3390/molecules25204758 33081296
    [Google Scholar]
  55. Xiao Q. Zoulikha M. Qiu M. Teng C. Lin C. Li X. Sallam M.A. Xu Q. He W. The effects of protein corona on in vivo fate of nanocarriers. Adv. Drug Deliv. Rev. 2022 186 114356 10.1016/j.addr.2022.114356 35595022
    [Google Scholar]
  56. Huang W. Xiao G. Zhang Y. Min W. Research progress and application opportunities of nanoparticle–protein corona complexes. Biomed. Pharmacother. 2021 139 111541 10.1016/j.biopha.2021.111541 33848776
    [Google Scholar]
  57. Walker S. Busatto S. Pham A. Tian M. Suh A. Carson K. Quintero A. Lafrence M. Malik H. Santana M.X. Wolfram J. Extracellular vesicle-based drug delivery systems for cancer treatment. Theranostics 2019 9 26 8001 8017 10.7150/thno.37097 31754377
    [Google Scholar]
  58. Fadeel B. Hide and seek: Nanomaterial interactions with the immune system. Front. Immunol. 2019 10 133 10.3389/fimmu.2019.00133 30774634
    [Google Scholar]
  59. Wu Y. Wan S. Yang S. Hu H. Zhang C. Lai J. Zhou J. Chen W. Tang X. Luo J. Zhou X. Yu L. Wang L. Wu A. Fan Q. Wu J. Macrophage cell membrane-based nanoparticles: A new promising biomimetic platform for targeted delivery and treatment. J. Nanobiotechnology 2022 20 1 542 10.1186/s12951‑022‑01746‑6 36575429
    [Google Scholar]
  60. Yuan P. Chen X. Li X. Zong X. Yang C. Li Y. Xue W. Dai J. Effect of cell membrane‐cloaked nanoparticle elasticity on nano‐bio interaction. Small Methods 2023 7 6 2201548 10.1002/smtd.202201548 36914575
    [Google Scholar]
  61. Liu Y. Wen N. Li K. Li M. Qian S. Li S. Jiang T. Wang T. Wu Y. Liu Z. Photolytic removal of red blood cell membranes camouflaged on nanoparticles for enhanced cellular uptake and combined chemo-photodynamic inhibition of cancer cells. Mol. Pharm. 2022 19 3 805 818 10.1021/acs.molpharmaceut.1c00720 35148115
    [Google Scholar]
  62. Rezaei S. de Araújo Júnior R.F. da Silva I.L.G. Schomann T. Eich C. Cruz L.J. Erythrocyte−cancer hybrid membrane-coated reduction-sensitive nanoparticles for enhancing chemotherapy efficacy in breast cancer. Biomaterials Advances 2023 151 213456 10.1016/j.bioadv.2023.213456 37196459
    [Google Scholar]
  63. Askenase P. Ancient origin properties of natural exosomes contribute to their therapeutic superiority compared to artificial nanoparticles. Preprint 2020 10.20944/preprints202006.0200.v1
    [Google Scholar]
  64. Lochhead J.J. Yang J. Ronaldson P.T. Davis T.P. Structure, function, and regulation of the blood-brain barrier tight junction in central nervous system disorders. Front. Physiol. 2020 11 914 10.3389/fphys.2020.00914 32848858
    [Google Scholar]
  65. Liu L. Bai X. Martikainen M.V. Kårlund A. Roponen M. Xu W. Hu G. Tasciotti E. Lehto V.P. Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles. Nat. Commun. 2021 12 1 5726 10.1038/s41467‑021‑26052‑x 34593813
    [Google Scholar]
  66. Xu B. Zhang Y. Du X.F. Li J. Zi H.X. Bu J.W. Yan Y. Han H. Du J.L. Neurons secrete miR-132-containing exosomes to regulate brain vascular integrity. Cell Res. 2017 27 7 882 897 10.1038/cr.2017.62 28429770
    [Google Scholar]
  67. Wang J. Yang L. The role of exosomes in central nervous system tissue regeneration and repair. Biomed. Mater. 2023 18 5 052003 10.1088/1748‑605X/ace39c 37399812
    [Google Scholar]
  68. Nanda A. Pandey P. Rajinikanth P.S. Singh N. Revolution of nanotechnology in food packaging: Harnessing electrospun zein nanofibers for improved preservation - A review. Int. J. Biol. Macromol. 2024 260 Pt 1 129416 10.1016/j.ijbiomac.2024.129416 38224810
    [Google Scholar]
  69. Kemp J.A. Kwon Y. J. Cancer nanotechnology: Current status and perspectives. Nano Converg. 2021 8 1 34 10.1186/s40580‑021‑00282‑7 34727233
    [Google Scholar]
  70. Debnath S.K. Srivastava R. Drug delivery with carbon-based nanomaterials as versatile nanocarriers: progress and prospects. Frontiers in Nanotechnology 2021 3 644564 10.3389/fnano.2021.644564
    [Google Scholar]
  71. Ozbek O. Genc D.E.O. Ulgen K. Advances in physiologically based pharmacokinetic (PBPK) modeling of nanomaterials. ACS Pharmacol. Transl. Sci. 2024 7 8 2251 2279 10.1021/acsptsci.4c00250 39144562
    [Google Scholar]
  72. Chan C. Nanoscale coordination polymers for chemotherapeutic and biological cancer therapy. Thesis, University of Chicago dissertations, 2019 10.6082/uchicago.2029
    [Google Scholar]
  73. Rambanapasi C. An assessment of the biodistribution, biopersistence and toxicity of gold nanoparticles. North-West University (South Africa). Potchefstroom Campus 2015
    [Google Scholar]
  74. Xu L. Liang H.W. Yang Y. Yu S.H. Stability and reactivity: Positive and negative aspects for nanoparticle processing. Chem. Rev. 2018 118 7 3209 3250 10.1021/acs.chemrev.7b00208 29517229
    [Google Scholar]
  75. García-Torra V. Cano A. Espina M. Ettcheto M. Camins A. Barroso E. Vazquez-Carrera M. García M.L. Sánchez-López E. Souto E.B. State of the art on toxicological mechanisms of metal and metal oxide nanoparticles and strategies to reduce toxicological risks. Toxics 2021 9 8 195 10.3390/toxics9080195 34437513
    [Google Scholar]
  76. Alalaiwe A. The clinical pharmacokinetics impact of medical nanometals on drug delivery system. Nanomedicine 2019 17 47 61 10.1016/j.nano.2019.01.004 30664946
    [Google Scholar]
  77. Khan M.I. Hossain M.I. Hossain M.K. Rubel M.H.K. Hossain K.M. Mahfuz A.M.U.B. Anik M.I. Recent progress in nanostructured smart drug delivery systems for cancer therapy: A review. ACS Appl. Bio Mater. 2022 5 3 971 1012 10.1021/acsabm.2c00002 35226465
    [Google Scholar]
  78. Liu Y. Zhu S. Gu Z. Chen C. Zhao Y. Toxicity of manufactured nanomaterials. Particuology 2022 69 31 48 10.1016/j.partic.2021.11.007
    [Google Scholar]
  79. Zhang P. Cao M. Chetwynd A.J. Faserl K. Abdolahpur Monikh F. Zhang W. Ramautar R. Ellis L.J.A. Davoudi H.H. Reilly K. Cai R. Wheeler K.E. Martinez D.S.T. Guo Z. Chen C. Lynch I. Analysis of nanomaterial biocoronas in biological and environmental surroundings. Nat. Protoc. 2024 19 10 3000 3047 10.1038/s41596‑024‑01009‑8 39044000
    [Google Scholar]
  80. Yang J. Hedin N. Advances of lab-scale analytical methods for solidification/stabilization technologies. Low Carbon Stabilization and Solidification of Hazardous Wastes. Elsevier 2022 483 495 10.1016/B978‑0‑12‑824004‑5.00006‑2
    [Google Scholar]
  81. Huang X. Liu H. Lu D. Lin Y. Liu J. Liu Q. Nie Z. Jiang G. Mass spectrometry for multi-dimensional characterization of natural and synthetic materials at the nanoscale. Chem. Soc. Rev. 2021 50 8 5243 5280 10.1039/D0CS00714E 33656017
    [Google Scholar]
  82. Liu Y. Workalemahu B. Jiang X. The effects of physicochemical properties of nanomaterials on their cellular uptake in vitro and in vivo. Small 2017 13 43 1701815 10.1002/smll.201701815 28941063
    [Google Scholar]
  83. Nie D. Liu C. Yu M. Jiang X. Wang N. Gan Y. Elasticity regulates nanomaterial transport as delivery vehicles: Design, characterization, mechanisms and state of the art. Biomaterials 2022 291 121879 10.1016/j.biomaterials.2022.121879 36343607
    [Google Scholar]
  84. Shinde P.V. Dutta D.P. Sharma R.P. Mane R.S. Surface-modified nanomaterials for biogenic applications. Nanomaterials for Sustainable Development: Opportunities and Future Perspectives. Springer 2023 101 135 10.1007/978‑981‑99‑1635‑1_4
    [Google Scholar]
  85. Zhao J. Stenzel M.H. Entry of nanoparticles into cells: The importance of nanoparticle properties. Polym. Chem. 2018 9 3 259 272 10.1039/C7PY01603D
    [Google Scholar]
  86. Rewatkar P. Kumeria T. Popat A. Size, shape and surface charge considerations of orally delivered nanomedicines. Nanotechnology for oral drug delivery. Elsevier 2020 143 176
    [Google Scholar]
  87. Sun T. Li C. Li X. Song H. Su B. You H. Zhang T. Jiang C. Pharmaceutical nanotechnology. Nanomedicine. Springer 2023 179 283
    [Google Scholar]
  88. Qiu Y. Liu Y. Wang L. Xu L. Bai R. Ji Y. Wu X. Zhao Y. Li Y. Chen C. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 2010 31 30 7606 7619 10.1016/j.biomaterials.2010.06.051 20656344
    [Google Scholar]
  89. Matuła K. Influence of physical and chemical factors on evolution of cells. Institute of Physical Chemistry PAS 2019
    [Google Scholar]
  90. Zhang J. He X. Zhang P. Ma Y. Ding Y. Wang Z. Zhang Z. Quantifying the dissolution of nanomaterials at the nano-bio interface. Sci. China Chem. 2015 58 5 761 767 10.1007/s11426‑015‑5401‑2
    [Google Scholar]
  91. Dykman L.A. Khlebtsov N.G. Uptake of engineered gold nanoparticles into mammalian cells. Chem. Rev. 2014 114 2 1258 1288 10.1021/cr300441a 24279480
    [Google Scholar]
  92. Mousavi S.M. Hashemi S.A. Mazraedoost S. Yousefi K. Gholami A. Behbudi G. Ramakrishna S. Omidifar N. Alizadeh A. Chiang W.H. Multifunctional gold nanorod for therapeutic applications and pharmaceutical delivery considering cellular metabolic responses, oxidative stress and cellular longevity. Nanomaterials 2021 11 7 1868 10.3390/nano11071868 34361251
    [Google Scholar]
  93. Greulich C. Diendorf J. Simon T. Eggeler G. Epple M. Köller M. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater. 2011 7 1 347 354 10.1016/j.actbio.2010.08.003 20709196
    [Google Scholar]
  94. Helmlinger J. Sengstock C. Groß-Heitfeld C. Mayer C. Schildhauer T.A. Köller M. Epple M. Silver nanoparticles with different size and shape: Equal cytotoxicity, but different antibacterial effects. RSC Advances 2016 6 22 18490 18501 10.1039/C5RA27836H
    [Google Scholar]
  95. Fleischer C.C. Payne C.K. Nanoparticle-cell interactions: Molecular structure of the protein corona and cellular outcomes. Acc. Chem. Res. 2014 47 8 2651 2659 10.1021/ar500190q 25014679
    [Google Scholar]
  96. Soenen S.J.H. Himmelreich U. Nuytten N. Pisanic T.R. Ferrari A. De Cuyper M. Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality. Small 2010 6 19 2136 2145 10.1002/smll.201000763 20818621
    [Google Scholar]
  97. Pelaz B. Charron G. Pfeiffer C. Zhao Y. de la Fuente J.M. Liang X.J. Parak W.J. del Pino P. Interfacing engineered nanoparticles with biological systems: Anticipating adverse nano-bio interactions. Small 2013 9 9-10 1573 1584 10.1002/smll.201201229 23112130
    [Google Scholar]
  98. Pooresmaeil M. Namazi H. Salehi R. Dual anticancer drug delivery of D-galactose-functionalized stimuli-responsive nanogels for targeted therapy of the liver hepatocellular carcinoma. Eur. Polym. J. 2022 167 111061 10.1016/j.eurpolymj.2022.111061
    [Google Scholar]
  99. Eshaghi B. Alsharif N. An X. Akiyama H. Brown K.A. Gummuluru S. Reinhard B.M. Stiffness of HIV‐1 mimicking polymer nanoparticles modulates ganglioside‐mediated cellular uptake and trafficking. Adv. Sci. 2020 7 18 2000649 10.1002/advs.202000649 32999830
    [Google Scholar]
  100. Foroozandeh P. Aziz A.A. Insight into cellular uptake and intracellular trafficking of nanoparticles. Nanoscale Res. Lett. 2018 13 1 339 10.1186/s11671‑018‑2728‑6 30361809
    [Google Scholar]
  101. Griffin B.T. Guo J. Presas E. Donovan M.D. Alonso M.J. O’Driscoll C.M. Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs. Adv. Drug Deliv Rev. 2016 106 Pt B 367-380 10.1016/j.addr.2016.06.006 27320644
    [Google Scholar]
  102. Szabo R. Bodolea C. Mocan T. Iron, copper, and zinc homeostasis: Physiology, physiopathology, and nanomediated applications. Nanomaterials 2021 11 11 2958 10.3390/nano11112958 34835722
    [Google Scholar]
  103. Singh B. Kumar A. Advances in microplastics detection: A comprehensive review of methodologies and their effectiveness. Trends Analyt. Chem. 2023 117440
    [Google Scholar]
  104. Alkilany A.M. Murphy C.J. Toxicity and cellular uptake of gold nanoparticles: What we have learned so far? J. Nanopart. Res. 2010 12 7 2313 2333 10.1007/s11051‑010‑9911‑8 21170131
    [Google Scholar]
  105. Ortiz-Castillo J.E. Gallo-Villanueva R.C. Madou M.J. Perez-Gonzalez V.H. Anisotropic gold nanoparticles: A survey of recent synthetic methodologies. Coord. Chem. Rev. 2020 425 213489 10.1016/j.ccr.2020.213489
    [Google Scholar]
  106. Li J. Song Y. Liu X. Zhang M. He R. Chang Y. Jin J. Xing G-M. Zhang J. The effects of C60(C(COOH)2)2-FITC on proliferation and differentiation of human mesenchymal stem cells in vitro. J. Nanosci. Nanotechnol. 2013 13 10 6517 6521 10.1166/jnn.2013.7166 24245108
    [Google Scholar]
  107. Sun Y. Sha Y. Cui G. Meng F. Zhong Z. Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy. Adv. Drug Deliv. Rev. 2023 192 114624 10.1016/j.addr.2022.114624 36435229
    [Google Scholar]
  108. Yang C. Wang X. Lysosome biogenesis: Regulation and functions. J. Cell Biol. 2021 220 6 e202102001 10.1083/jcb.202102001 33950241
    [Google Scholar]
  109. Kühling L. Schelhaas M. Systematic analysis of endocytosis by cellular perturbations. In: Exocytosis and Endocytosis Methods in Molecular Biology. New York Humana Press 2014 19 46 10.1007/978‑1‑4939‑0944‑5_2
    [Google Scholar]
  110. Makvandi P. Chen M. Sartorius R. Zarrabi A. Ashrafizadeh M. Dabbagh Moghaddam F. Ma J. Mattoli V. Tay F.R. Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking. Nano Today 2021 40 101279 10.1016/j.nantod.2021.101279 34518771
    [Google Scholar]
  111. Preta G. Cronin J.G. Sheldon I.M. Dynasore - not just a dynamin inhibitor. Cell Commun. Signal. 2015 13 1 24 10.1186/s12964‑015‑0102‑1 25889964
    [Google Scholar]
  112. Ray A. Mitra A.K. Nanotechnology in intracellular trafficking, imaging, and delivery of therapeutic agents. Emerging nanotechnologies for diagnostics, drug delivery and medical devices. Elsevier 2017 169 188 10.1016/B978‑0‑323‑42978‑8.00008‑5
    [Google Scholar]
  113. Parthasarathi S. Anandharamakrishnan C. Biological fate of nanoparticles. Food. Nanotechnology. CRC Press 2019 259 274 10.1201/9781315153872‑12
    [Google Scholar]
  114. Zhang A. Fang J. Li X. Wang J. Chen M. Chen H. He G. Xie X. Cellular nanointerface of vertical nanostructure arrays and its applications. Nanoscale Adv. 2022 4 8 1844 1867 10.1039/D1NA00775K 36133409
    [Google Scholar]
  115. Fadeel B. Nanomaterial characterization: Understanding nano-bio interactions. Biochem. Biophys. Res. Commun. 2022 633 45 51 10.1016/j.bbrc.2022.08.095 36344160
    [Google Scholar]
  116. Pääkkö P. Anttila S. Sutinen S. Hakala M. Lysosomal gold accumulations in pulmonary macrophages. Ultrastruct. Pathol. 1984 7 4 289 294 10.3109/01913128409141489 6537095
    [Google Scholar]
  117. Simpson J.D. Smith S.A. Thurecht K.J. Such G. Engineered polymeric materials for biological applications: Overcoming challenges of the bio–nano interface. Polymers 2019 11 9 1441 10.3390/polym11091441 31480780
    [Google Scholar]
  118. Zhao Z. Ukidve A. Krishnan V. Mitragotri S. Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers. Adv. Drug Deliv. Rev. 2019 143 3 21 10.1016/j.addr.2019.01.002 30639257
    [Google Scholar]
  119. Demir E. A review on nanotoxicity and nanogenotoxicity of different shapes of nanomaterials. J. Appl. Toxicol. 2021 41 1 118 147 10.1002/jat.4061 33111384
    [Google Scholar]
  120. Ng C.T. Tang F.M.A. Li J.J. Ong C. Yung L.L.Y. Bay B.H. Clathrin-mediated endocytosis of gold nanoparticles in vitro. Anat. Rec. 2015 298 2 418 427 10.1002/ar.23051 25243822
    [Google Scholar]
  121. Chithrani D.B. Dunne M. Stewart J. Allen C. Jaffray D.A. Cellular uptake and transport of gold nanoparticles incorporated in a liposomal carrier. Nanomedicine 2010 6 1 161 169 10.1016/j.nano.2009.04.009 19447206
    [Google Scholar]
  122. Pan H. Low S. Weerasuriya N. Shon Y.S. Graphene oxide-promoted reshaping and coarsening of gold nanorods and nanoparticles. ACS Appl. Mater. Interfaces 2015 7 5 3406 3413 10.1021/am508801e 25611371
    [Google Scholar]
  123. Nosaka Y. Nosaka A.Y. Generation and detection of reactive oxygen species in photocatalysis. Chem. Rev. 2017 117 17 11302 11336 10.1021/acs.chemrev.7b00161 28777548
    [Google Scholar]
  124. Derfus A.M. Chan W.C.W. Bhatia S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 2004 4 1 11 18 10.1021/nl0347334 28890669
    [Google Scholar]
  125. Pearce C.I. Pattrick R.A.D. Law N. Charnock J.M. Coker V.S. Fellowes J.W. Oremland R.S. Lloyd J.R. Investigating different mechanisms for biogenic selenite transformations: Geobacter sulfurreducens, Shewanella oneidensis and Veillonella atypica. Environ. Technol. 2009 30 12 1313 1326 10.1080/09593330902984751 19950474
    [Google Scholar]
  126. Hu Y. Wang Y. Han X. Shan Y. Li F. Shi L. Biofilm biology and engineering of Geobacter and Shewanella spp. for energy applications. Front. Bioeng. Biotechnol. 2021 9 786416 10.3389/fbioe.2021.786416 34926431
    [Google Scholar]
  127. Chen R. Riviere J.E. Biological and environmental surface interactions of nanomaterials: Characterization, modeling, and prediction. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2017 9 3 e1440 10.1002/wnan.1440 27863136
    [Google Scholar]
  128. Foroozandeh P. Aziz A.A. Merging worlds of nanomaterials and biological environment: Factors governing protein corona formation on nanoparticles and its biological consequences. Nanoscale Res. Lett. 2015 10 1 221 10.1186/s11671‑015‑0922‑3 25995715
    [Google Scholar]
  129. Abbas Q. Yousaf B. Amina; Ali, M.U.; Munir, M.A.M.; El-Naggar, A.; Rinklebe, J.; Naushad, M. Transformation pathways and fate of engineered nanoparticles (ENPs) in distinct interactive environmental compartments: A review. Environ. Int. 2020 138 105646 10.1016/j.envint.2020.105646 32179325
    [Google Scholar]
  130. Ren J. Bao Q. Yang Y. Tang Y. Zhang N. Liu G. Zhang S. Gao H. Liu S. Nano–eco interactions: A crucial principle for nanotoxicity evaluation. Environ. Sci. Nano 2023 10 12 3253 3270 10.1039/D3EN00617D
    [Google Scholar]
  131. Tripathi D. Shukla V. Sahoo J. Sharma D.K. Shukla T. Engineered tissue in cancer research: Techniques, challenges, and current status Targeted Cancer Therapy in Biomedical Engineering. Springer 2023 291 324 10.1007/978‑981‑19‑9786‑0_8
    [Google Scholar]
  132. Bahadar H. Maqbool F. Niaz K. Abdollahi M. Toxicity of nanoparticles and an overview of current experimental models. Iran. Biomed. J. 2016 20 1 1 11 26286636
    [Google Scholar]
  133. Aresh W. Lipid-Based Self-Assembled NPs: The Effects of Morphology and Targeting Molecules on the Cellular Uptake Using in vitro Tumor Mode. University of Connecticut 2017
    [Google Scholar]
  134. Richards D.M. Endres R.G. How cells engulf: A review of theoretical approaches to phagocytosis. Rep. Prog. Phys. 2017 80 12 126601 10.1088/1361‑6633/aa8730 28824015
    [Google Scholar]
  135. Moyano D.F. Liu Y. Peer D. Rotello V.M. Modulation of immune response using engineered nanoparticle surfaces. Small 2016 12 1 76 82 10.1002/smll.201502273 26618755
    [Google Scholar]
  136. Tripathi D. Gupta T. Pandey P. Exploring piperine: Unleashing the multifaceted potential of a phytochemical in cancer therapy. Mol. Biol. Rep. 2024 51 1 1050 10.1007/s11033‑024‑09978‑5 39395120
    [Google Scholar]
  137. Carnovale C. Bryant G. Shukla R. Bansal V. Size, shape and surface chemistry of nano-gold dictate its cellular interactions, uptake and toxicity. Prog. Mater. Sci. 2016 83 152 190 10.1016/j.pmatsci.2016.04.003
    [Google Scholar]
  138. Tripathi D. A review on use of some herbal medicinal plants in treatment of cerebral stroke. Int. J. Pharm. Res. Scholars 2016 5 4 128 134
    [Google Scholar]
  139. Pandey P. Chaudhary R. Tripathi D. Lavudi K. Dua K. Weinfeld M. Lavasanifar A. Rajinikanth P.S. Personalized treatment approach for HER2-positive metastatic breast cancer. Med. Oncol. 2024 41 11 252 10.1007/s12032‑024‑02504‑4 39320608
    [Google Scholar]
  140. Hussain Z. Khan S. Imran M. Sohail M. Shah S.W.A. de Matas M. PEGylation: A promising strategy to overcome challenges to cancer-targeted nanomedicines: A review of challenges to clinical transition and promising resolution. Drug Deliv. Transl. Res. 2019 9 3 721 734 10.1007/s13346‑019‑00631‑4 30895453
    [Google Scholar]
  141. Park J. Nam J. Won N. Jin H. Jung S. Jung S. Cho S.H. Kim S. Compact and stable quantum dots with positive, negative, or zwitterionic surface: specific cell interactions and non‐specific adsorptions by the surface charges. Adv. Funct. Mater. 2011 21 9 1558 1566 10.1002/adfm.201001924
    [Google Scholar]
  142. Malhotra K. Fuku R. Chan T.S. Kraljevic N. Sedighi A. Piunno P.A.E. Krull U.J. Bisphosphonate polymeric ligands on inorganic nanoparticles. Chem. Mater. 2020 32 9 4002 4012 10.1021/acs.chemmater.0c00547
    [Google Scholar]
  143. Rana S. Bajaj A. Mout R. Rotello V.M. Monolayer coated gold nanoparticles for delivery applications. Adv. Drug Deliv. Rev. 2012 64 2 200 216 10.1016/j.addr.2011.08.006 21925556
    [Google Scholar]
  144. Mukherjee M. Purkayastha P. The influence of gold nanoparticles on reduction of [Co(NH3)5Br](NO3)2 by iron(II). SN Appl. Sci. 2020 2 618
    [Google Scholar]
  145. Chaurasiya B. Mahanty A. Roy D. Shen Y. Tu J. Sun C. Influence of tumor microenvironment on the distribution and elimination of nano-formulations. Curr. Drug Metab. 2016 17 8 783 798 10.2174/1389200217666160607093347 27280439
    [Google Scholar]
  146. Lee K.Y.J. Lee G.Y. Lane L.A. Li B. Wang J. Lu Q. Wang Y. Nie S. Functionalized, long-circulating, and ultrasmall gold nanocarriers for overcoming the barriers of low nanoparticle delivery efficiency and poor tumor penetration. Bioconjug. Chem. 2017 28 1 244 252 10.1021/acs.bioconjchem.6b00224 27341302
    [Google Scholar]
  147. Zhao J. Lee P. Wallace M. Melancon M. Gold nanoparticles in cancer therapy: Efficacy, biodistribution, and toxicity. Curr. Pharm. Des. 2015 21 29 4240 4251 10.2174/1381612821666150901103032 26323426
    [Google Scholar]
  148. Li X. Montague E.C. Pollinzi A. Lofts A. Hoare T. Design of smart size‐, surface‐, and shape‐switching nanoparticles to improve therapeutic efficacy. Small 2022 18 6 2104632 10.1002/smll.202104632 34936204
    [Google Scholar]
  149. Gupta N. Malviya R. Understanding and advancement in gold nanoparticle targeted photothermal therapy of cancer. Biochim. Biophys. Acta Rev. Cancer 2021 1875 2 188532 10.1016/j.bbcan.2021.188532 33667572
    [Google Scholar]
  150. Iyer R. Ramachandramoorthy H. Nguyen T. Xu C. Fu H. Kotadia T. Chen B. Hong Y. Saha D. Nguyen K.T. Lung cancer targeted chemoradiotherapy via dual-stimuli responsive biodegradable core-shell nanoparticles. Pharmaceutics 2022 14 8 1525 10.3390/pharmaceutics14081525 35893781
    [Google Scholar]
  151. Oldenborg P.A. CD47: A cell surface glycoprotein which regulates multiple functions of hematopoietic cells in health and disease. ISRN Hematol. 2013 2013 1 19 10.1155/2013/614619 23401787
    [Google Scholar]
  152. Gheibi Hayat S.M. Bianconi V. Pirro M. Sahebkar A. Stealth functionalization of biomaterials and nanoparticles by CD47 mimicry. Int. J. Pharm. 2019 569 118628 10.1016/j.ijpharm.2019.118628 31421198
    [Google Scholar]
  153. Kumar P Srivastava R Nanomedicine for cancer therapy. Nanomedicine for cancer therapy: From chemotherapeutic to hyperthermia-based therapy 2016 10.1007/978‑3‑319‑45826‑7_1
    [Google Scholar]
  154. Niculescu A.G. Grumezescu A.M. Novel tumor-targeting nanoparticles for cancer treatment—A review. Int. J. Mol. Sci. 2022 23 9 5253 10.3390/ijms23095253 35563645
    [Google Scholar]
  155. Sun M. Yang J. Fan Y. Zhang Y. Sun J. Hu M. Sun K. Zhang J. Beyond extracellular vesicles: Hybrid membrane nanovesicles as emerging advanced tools for biomedical applications. Adv. Sci. 2023 10 32 2303617 10.1002/advs.202303617 37749882
    [Google Scholar]
  156. Bigaj-Józefowska M.J. Grześkowiak B.F. Polymeric nanoparticles wrapped in biological membranes for targeted anticancer treatment. Eur. Polym. J. 2022 176 111427 10.1016/j.eurpolymj.2022.111427
    [Google Scholar]
  157. Tang L. He S. Yin Y. Liu H. Hu J. Cheng J. Wang W. Combination of nanomaterials in cell-based drug delivery systems for cancer treatment. Pharmaceutics 2021 13 11 1888 10.3390/pharmaceutics13111888 34834304
    [Google Scholar]
  158. Shi W. Qiu Q. Feng Z. Tong Z. Guo W. Zou F. Yue N. Huang W. Qian H. Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: A broad-spectrum candidate for an effective antibreast cancer therapy. J. Immunother. Cancer 2021 9 6 e002523 10.1136/jitc‑2021‑002523 34083420
    [Google Scholar]
  159. Asal M. Güven S. Stem cells: Sources, properties, and cell types. In: Biomaterials for organ and tissue regeneration. Elsevier 2020 177 196
    [Google Scholar]
  160. Chowdhury S. Ghosh S. Chowdhury S. Ghosh S. Stem cells an overview. Stem Cells Biol. Ther 2021 1 21
    [Google Scholar]
  161. Kim S.W. Lee Y.K. Hong J.H. Park J.Y. Choi Y.A. Lee D.U. Choi J. Sym S.J. Kim S.H. Khang D. Mutual destruction of deep lung tumor tissues by nanodrug-conjugated stealth mesenchymal stem cells. Adv. Sci. 2018 5 5 1700860 10.1002/advs.201700860 29876212
    [Google Scholar]
  162. Takayama Y. Kusamori K. Tsukimori C. Shimizu Y. Hayashi M. Kiyama I. Katsumi H. Sakane T. Yamamoto A. Nishikawa M. Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy. J. Control. Release 2021 329 1090 1101 10.1016/j.jconrel.2020.10.037 33098911
    [Google Scholar]
  163. Soprano E. Polo E. Pelaz B. del Pino P. Biomimetic cell-derived nanocarriers in cancer research. J. Nanobiotechnology 2022 20 1 538 10.1186/s12951‑022‑01748‑4 36544135
    [Google Scholar]
  164. Wu D. Chen Q. Chen X. Han F. Chen Z. Wang Y. The blood–brain barrier: Structure, regulation and drug delivery. Signal Transduct. Target. Ther. 2023 8 1 217 10.1038/s41392‑023‑01481‑w 37231000
    [Google Scholar]
  165. Al-Ahmady Z.S. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption. Expert Opin. Drug Deliv. 2018 15 4 335 349 10.1080/17425247.2018.1444601 29466890
    [Google Scholar]
  166. Sánchez-López E. Ettcheto M. Egea M.A. Espina M. Cano A. Calpena A.C. Camins A. Carmona N. Silva A.M. Souto E.B. García M.L. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: In vitro and in vivo characterization. J. Nanobiotechnology 2018 16 1 32 10.1186/s12951‑018‑0356‑z 29587747
    [Google Scholar]
  167. Upadhyay R.K. Drug delivery systems, CNS protection, and the blood brain barrier. BioMed Res. Int. 2014 2014 1 37 10.1155/2014/869269 25136634
    [Google Scholar]
  168. Challa Y.R. Senthil V. Jawahar N. Bairi R. Natural compound loaded nanoparticles for effective treatment of Alzheimer’s disease-A review. Nat. Volat Essent Oils J. 2021 8 5 12625 12649
    [Google Scholar]
  169. Fornaguera C. Feiner-Gracia N. Calderó G. García-Celma M.J. Solans C. Galantamine-loaded PLGA nanoparticles, from nano-emulsion templating, as novel advanced drug delivery systems to treat neurodegenerative diseases. Nanoscale 2015 7 28 12076 12084 10.1039/C5NR03474D 26118655
    [Google Scholar]
  170. Ramalho M.J. Bravo M. Loureiro J.A. Lima J. Pereira M.C. Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells. Life Sci. 2022 296 120435 10.1016/j.lfs.2022.120435 35247437
    [Google Scholar]
  171. Samanthula K.S. Alli R. Gorre T. Preparation, in vitro characterization and stability studies of ropinirole lipid nanoparticles enriched hydrogel for treatment of neurodegeneration diseases. J. Drug Deliv. Ther. 2021 11 2-S 66 75 10.22270/jddt.v11i2‑S.4648
    [Google Scholar]
  172. Thirugnanam T. Santhakumar K. Chemically induced models of Parkinson’s disease. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2022 252 109213 10.1016/j.cbpc.2021.109213 34673252
    [Google Scholar]
  173. Attia M.S. Yahya A. Monaem N.A. Sabry S.A. Mesoporous silica nanoparticles: Their potential as drug delivery carriers and nanoscavengers in Alzheimer’s and Parkinson’s diseases. Saudi Pharm. J. 2023 31 3 417 432 10.1016/j.jsps.2023.01.009 37026045
    [Google Scholar]
  174. Ankita A. Chahal S. Singh S. Kumar S. Kumar P. Europium-doped cerium oxide nanoparticles: Investigating oxygen vacancies and their role in enhanced photocatalytic and magnetic properties. Environ. Sci. Pollut. Res. Int. 2023 31 1 1276 1287 10.1007/s11356‑023‑30686‑3 38038920
    [Google Scholar]
  175. Rabiee N. Ahmadi S. Afshari R. Khalaji S. Rabiee M. Bagherzadeh M. Fatahi Y. Dinarvand R. Tahriri M. Tayebi L. Hamblin M.R. Webster T.J. Polymeric nanoparticles for nasal drug delivery to the brain: Relevance to Alzheimer’s disease. Adv. Ther. 2021 4 3 2000076 10.1002/adtp.202000076
    [Google Scholar]
  176. Shukla S. Hernandez C. Liposome based drug delivery as a potential treatment option for Alzheimer’s disease. Neural Regen. Res. 2022 17 6 1190 1198 10.4103/1673‑5374.327328 34782553
    [Google Scholar]
  177. Poudel P. Park S. Recent advances in the treatment of Alzheimer’s disease using nanoparticle-based drug delivery systems. Pharmaceutics 2022 14 4 835 10.3390/pharmaceutics14040835 35456671
    [Google Scholar]
  178. Umar M. Rehman Y. Ambreen S. Mumtaz S.M. Shaququzzaman M. Alam M.M. Ali R. Innovative approaches to Alzheimer’s therapy: Harnessing the power of heterocycles, oxidative stress management, and nanomaterial drug delivery system. Ageing Res. Rev. 2024 97 102298 10.1016/j.arr.2024.102298 38604453
    [Google Scholar]
  179. Wilson B. Samanta M.K. Santhi K. Sampath Kumar K.P. Ramasamy M. Suresh B. Significant delivery of tacrine into the brain using magnetic chitosan microparticles for treating Alzheimer’s disease. J. Neurosci. Methods 2009 177 2 427 433 10.1016/j.jneumeth.2008.10.036 19041670
    [Google Scholar]
  180. Gupta J. Fatima M.T. Islam Z. Khan R.H. Uversky V.N. Salahuddin P. Nanoparticle formulations in the diagnosis and therapy of Alzheimer’s disease. Int. J. Biol. Macromol. 2019 130 515 526 10.1016/j.ijbiomac.2019.02.156 30826404
    [Google Scholar]
  181. Delkhahi S. Rahaie M. Rahimi F. Design and fabrication a gold nanoparticle-DNA based nanobiosensor for detection of microRNA involved in Alzheimer’s disease. J. Fluoresc. 2017 27 2 603 610 10.1007/s10895‑016‑1988‑8 27909844
    [Google Scholar]
  182. Hadavi D. Poot A.A. Biomaterials for the treatment of alzheimer’s disease. Front. Bioeng. Biotechnol. 2016 4 49 10.3389/fbioe.2016.00049 27379232
    [Google Scholar]
  183. Migliore L. Uboldi C. Di Bucchianico S. Coppedè F. Nanomaterials and neurodegeneration. Environ. Mol. Mutagen. 2015 56 2 149 170 10.1002/em.21931 25627719
    [Google Scholar]
  184. Ramesh S. Arachchige A.S.P.M. Depletion of dopamine in Parkinson’s disease and relevant therapeutic options: A review of the literature. AIMS Neurosci. 2023 10 3 200 231 10.3934/Neuroscience.2023017 37841347
    [Google Scholar]
  185. Fernanda Veloz-Castillo, M Nanomaterials for neurology: State-of-the-art. CNS Neurol. Disord. Drug Targets 2016 15 1306 1324
    [Google Scholar]
  186. Cheng G. Liu Y. Ma R. Cheng G. Guan Y. Chen X. Wu Z. Chen T. Anti-Parkinsonian therapy: Strategies for crossing the blood–brain barrier and nano-biological effects of nanomaterials. Nano-Micro Lett. 2022 14 1 105 10.1007/s40820‑022‑00847‑z 35426525
    [Google Scholar]
  187. Wang S. Yang L. He W. Zheng M. Zou Y. Cell membrane camouflaged biomimetic nanoparticles as a versatile platform for brain diseases treatment. Small Methods 2024 2400096 38461538
    [Google Scholar]
  188. Zhang R. Chen X. Cheng Y. Chen Z. Li X. Deng Y. Recent advances of nanomaterials for intervention in Parkinson’s disease in the context of anti-inflammation. Coord. Chem. Rev. 2024 502 215616 10.1016/j.ccr.2023.215616
    [Google Scholar]
  189. Chen Y. Wei C. Lyu Y. Chen H. Jiang G. Gao X. Biomimetic drug-delivery systems for the management of brain diseases. Biomater. Sci. 2020 8 4 1073 1088 10.1039/C9BM01395D 31728485
    [Google Scholar]
  190. Upadhya R. Shetty A.K. Extracellular vesicles for the diagnosis and treatment of Parkinson’s disease. Aging Dis. 2021 12 6 1438 1450 10.14336/AD.2021.0516 34527420
    [Google Scholar]
  191. Lu Y. Han S. Zheng H. Ma R. Ping Y. Zou J. Tang H. Zhang Y. Xu X. Li F. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system. Int. J. Nanomedicine 2018 13 5937 5952 10.2147/IJN.S175418 30323584
    [Google Scholar]
  192. Ouyang J. Xie A. Zhou J. Liu R. Wang L. Liu H. Kong N. Tao W. Minimally invasive nanomedicine: Nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging. Chem. Soc. Rev. 2022 51 12 4996 5041 10.1039/D1CS01148K 35616098
    [Google Scholar]
  193. Cervantes Gracia K. Llanas-Cornejo D. Husi H. CVD and oxidative stress. J. Clin. Med. 2017 6 2 22 10.3390/jcm6020022 28230726
    [Google Scholar]
  194. Kalra B.S. Batta A. Khirasaria R. Critical issues and recent advances in anticoagulant therapy: A review. Neurol. India 2019 67 5 1200 1212 10.4103/0028‑3886.271256 31744944
    [Google Scholar]
  195. Kennedy I.M. Wilson D. Barakat A.I. Uptake and inflammatory effects of nanoparticles in a human vascular endothelial cell line. Res. Rep. Health Eff. Inst. 2009 136 3 32 19552347
    [Google Scholar]
  196. Pegoraro C. Domingo-Ortí I. Conejos-Sánchez I. Vicent M.J. Unlocking the mitochondria for nanomedicine-based treatments: Overcoming biological barriers, improving designs, and selecting verification techniques. Adv. Drug Deliv. Rev. 2024 207 115195 10.1016/j.addr.2024.115195 38325562
    [Google Scholar]
  197. Peng Y. Yang Z. Sun H. Li J. Lan X. Liu S. Nanomaterials in medicine: Understanding cellular uptake, localization, and retention for enhanced disease diagnosis and therapy. Aging Dis. 2025 16 1 168 208 10.14336/AD.2024.0206‑1 38421835
    [Google Scholar]
  198. Madani F. Esnaashari S.S. Webster T.J. Khosravani M. Adabi M. Polymeric nanoparticles for drug delivery in glioblastoma: State of the art and future perspectives. J. Control. Release 2022 349 649 661 10.1016/j.jconrel.2022.07.023 35878729
    [Google Scholar]
  199. Strobel H.A. Qendro E.I. Alsberg E. Rolle M.W. Targeted delivery of bioactive molecules for vascular intervention and tissue engineering. Front. Pharmacol. 2018 9 1329 10.3389/fphar.2018.01329 30519186
    [Google Scholar]
  200. Ahadian S. Davenport Huyer L. Estili M. Yee B. Smith N. Xu Z. Sun Y. Radisic M. Moldable elastomeric polyester-carbon nanotube scaffolds for cardiac tissue engineering. Acta Biomater. 2017 52 81 91 10.1016/j.actbio.2016.12.009 27940161
    [Google Scholar]
  201. Matoba T. Koga J. Nakano K. Egashira K. Tsutsui H. Nanoparticle-mediated drug delivery system for atherosclerotic cardiovascular disease. J. Cardiol. 2017 70 3 206 211 10.1016/j.jjcc.2017.03.005 28416142
    [Google Scholar]
  202. Sharma N. Wani S.N. Singh S. Zahoor I. Behl T. Malik I.A. Decrypting the role of angiogenesis, inflammation, and oxidative stress in pathogenesis of congestive heart failure: Nanotechnology as a boon for the management of congestive heart failure. Targeting Angiogenesis, Inflammation, and Oxidative Stress in Chronic Diseases. Elsevier 2024 151 190
    [Google Scholar]
  203. Younis N.K. Ghoubaira J.A. Bassil E.P. Tantawi H.N. Eid A.H. Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases. Nanomedicine 2021 36 102433 10.1016/j.nano.2021.102433
    [Google Scholar]
  204. Lazana I. Anagnostopoulos C. A novel, cell-free therapy to enter our hearts: The potential role of small EVs in prevention and treatment of CVD. Int. J. Mol. Sci. 2022 23 7 3662 10.3390/ijms23073662 35409022
    [Google Scholar]
  205. Jeong J.H. Kang S.H. Kim D.K. Lee N.S. Jeong Y.G. Han S.Y. Protective effect of cholic acid-coated poly lactic-co-glycolic acid (PLGA) nanoparticles loaded with erythropoietin on experimental stroke. J. Nanosci. Nanotechnol. 2019 19 10 6524 6533 10.1166/jnn.2019.17078 31026988
    [Google Scholar]
  206. Wang A. Yue K. Zhong W. Zhang G. Zhang X. Wang L. Targeted delivery of rapamycin and inhibition of platelet adhesion with multifunctional peptide nanoparticles for atherosclerosis treatment.Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery. J. Control. ReleaseBiomaterials 2024 376 753 765 10.1016/j.jconrel.2024.10.051 39490419
    [Google Scholar]
  207. Parodi A. Molinaro R. Sushnitha M. Evangelopoulos M. Martinez J.O. Arrighetti N. Corbo C. Tasciotti E. Targeted delivery of rapamycin and inhibition of platelet adhesion with multifunctional peptide nanoparticles for atherosclerosis treatment.Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery. J. Control. ReleaseBiomaterials 2017 147 155 168 10.1016/j.biomaterials.2017.09.020 28946131
    [Google Scholar]
  208. Martinez J.O. Molinaro R. Hartman K.A. Boada C. Sukhovershin R. De Rosa E. Kuri D. Zhang S. Evangelopoulos M. Carter A.M. Bibb J.A. Cooke J.P. Tasciotti E. Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery. Theranostics 2018 8 4 1131 1145 10.7150/thno.22078 29464004
    [Google Scholar]
  209. Kuriakose D. Xiao Z. Pathophysiology and treatment of stroke: present status and future perspectives. Int. J. Mol. Sci. 2020 21 20 7609 10.3390/ijms21207609 33076218
    [Google Scholar]
  210. Zheng Y. Wu Y. Liu Y. Guo Z. Bai T. Zhou P. Wu J. Yang Q. Liu Z. Lu X. Intrinsic effects of gold nanoparticles on oxygen–glucose deprivation/reperfusion injury in rat cortical neurons. Neurochem. Res. 2019 44 7 1549 1566 10.1007/s11064‑019‑02776‑7 31093902
    [Google Scholar]
  211. Song G. Zhao M. Chen H. Lenahan C. Zhou X. Ou Y. He Y. The role of nanomaterials in stroke treatment: Targeting oxidative stress. Oxid. Med. Cell. Longev. 2021 2021 1 8857486 10.1155/2021/8857486 33815664
    [Google Scholar]
  212. Ben-Akiva E. Meyer R.A. Yu H. Smith J.T. Pardoll D.M. Green J.J. Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal. Sci. Adv. 2020 6 16 eaay9035 10.1126/sciadv.aay9035 32490199
    [Google Scholar]
  213. Lin Y. Liu J. Bai R. Shi J. Zhu X. Liu J. Guo J. Zhang W. Liu H. Liu Z. Mitochondria-inspired nanoparticles with microenvironment-adapting capacities for on-demand drug delivery after ischemic injury. ACS Nano 2020 14 9 11846 11859 10.1021/acsnano.0c04727 32880428
    [Google Scholar]
  214. Nong J. Glassman P.M. Reyes-Esteves S. Descamps H.C. Shuvaev V.V. Kiseleva R.Y. Papp T.E. Alameh M-G. Tam Y.K. Mui B.L. Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic stroke. BioRxiv 2023
    [Google Scholar]
  215. He W. Zhang Z. Sha X. Nanoparticles-mediated emerging approaches for effective treatment of ischemic stroke. Biomaterials 2021 277 121111 10.1016/j.biomaterials.2021.121111 34488117
    [Google Scholar]
  216. Shaukat N. Nisar S. Jan O.A. Sajid U. Mahmood A. Zahid H. The role of citicoline in neuroprotection and neuro repair in acute stroke. Pak. Armed Forces Med. J. 2023 73 4 1161 1164 10.51253/pafmj.v73i4.4956
    [Google Scholar]
  217. Lv W. Xu J. Wang X. Li X. Xu Q. Xin H. Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke treatment. ACS Nano 2018 12 6 5417 5426 10.1021/acsnano.8b00477 29869497
    [Google Scholar]
  218. He L. Huang G. Liu H. Sang C. Liu X. Chen T. Highly bioactive zeolitic imidazolate framework-8–capped nanotherapeutics for efficient reversal of reperfusion-induced injury in ischemic stroke. Sci. Adv. 2020 6 12 eaay9751 10.1126/sciadv.aay9751 32206718
    [Google Scholar]
  219. Suzuki I. Xing H. Giblin J. Ashraf A. Chung E.J. Nanoparticle‐based therapeutic strategies for mitochondrial dysfunction in cardiovascular disease. J. Biomed. Mater. Res. A 2024 112 6 895 913 10.1002/jbm.a.37668 38217313
    [Google Scholar]
  220. Gil-Cabrerizo P. Simon-Yarza T. Garbayo E. Blanco-Prieto M.J. Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics. Adv. Drug Deliv. Rev. 2024 208 115302 10.1016/j.addr.2024.115302 38574952
    [Google Scholar]
  221. Sen S. Ranjan O.P. Nanofibrous textile scaffolds: A new innovation in nanotechnology for tissue engineering. In: Nanotechnology Based Advanced Medical Textiles and Biotextiles for Healthcare. CRC Press 2024 281 296 10.1201/9781003331612‑16
    [Google Scholar]
  222. Pandey G. Pandey P. Arya D.K. Kanaujiya S. Kapoor D.D. Gupta R.K. Ranjan S. Chidambaram K. Manickam B. Multilayered nanofibrous scaffold of polyvinyl alcohol/gelatin/poly(lactic-co-glycolic acid) enriched with hemostatic/antibacterial agents for rapid acute hemostatic wound healing. Int. J. Pharm. 2023 638 122918 10.1016/j.ijpharm.2023.122918
    [Google Scholar]
  223. Singh P. Pandey P. Arya D.K. Anjum M.M. Poonguzhali S. Kumar A. Gupta R. Rajamanickam V.M. Singh S. Chaurasia, SJBM Biomimicking dual drug eluting twisted electrospun nanofiber yarns for post-operative wound healing. Biomed. Mater. 2023 18 3 10.1088/1748‑605X/acc4a1
    [Google Scholar]
  224. Jin C. Chen D. Zhu T. Chen S. Du J. Zhang H. Dong W. Poly(ferulic acid)-hybrid nanofibers for reducing thrombosis and restraining intimal hyperplasia in vascular tissue engineering. Biomaterials Advances 2023 146 213278 10.1016/j.bioadv.2023.213278 36638698
    [Google Scholar]
  225. Ramezani M. Ripin Z.M. An overview of enhancing the performance of medical implants with nanocomposites. J. Compos Sci. 2023 7 5 199 10.3390/jcs7050199
    [Google Scholar]
  226. Salaudeen M.A. Therapeutic potentials of hydrogels and nanogels in CNS disorders. In: Hydrogels and Nanogels - Applications in Medicine. IntechOpen 2023 10.5772/intechopen.1002026
    [Google Scholar]
  227. Bordoni M. Scarian E. Rey F. Gagliardi S. Carelli S. Pansarasa O. Cereda C. Biomaterials in neurodegenerative disorders: A promising therapeutic approach. Int. J. Mol. Sci. 2020 21 9 3243 10.3390/ijms21093243 32375302
    [Google Scholar]
  228. Teixeira M.I. Lopes C.M. Amaral M.H. Costa P.C. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases. Eur. J. Pharm. Biopharm. 2020 149 192 217 10.1016/j.ejpb.2020.01.005 31982574
    [Google Scholar]
  229. Duan L. Li X. Ji R. Hao Z. Kong M. Wen X. Guan F. Ma S. Nanoparticle-based drug delivery systems: An inspiring therapeutic strategy for neurodegenerative diseases. Polymers 2023 15 9 2196 10.3390/polym15092196 37177342
    [Google Scholar]
  230. Riccardi C. Napolitano F. Montesarchio D. Sampaolo S. Melone M.A.B. Nanoparticle-guided brain drug delivery: Expanding the therapeutic approach to neurodegenerative diseases. Pharmaceutics 2021 13 11 1897 10.3390/pharmaceutics13111897 34834311
    [Google Scholar]
  231. Anwar A. Teow S-Y. Wu Y.S. Nanogel-based drug delivery system as a treatment modality for diverse diseases: Are we there yet? J. Drug Deliv. Sci. Technol. 2023 105224
    [Google Scholar]
  232. Iacovita C. Fizeșan I. Pop A. Scorus L. Dudric R. Stiufiuc G. Vedeanu N. Tetean R. Loghin F. Stiufiuc R. Lucaciu C.M. In vitro intracellular hyperthermia of iron oxide magnetic nanoparticles, synthesized at high temperature by a polyol process. Pharmaceutics 2020 12 5 424 10.3390/pharmaceutics12050424 32384665
    [Google Scholar]
  233. Chiang M.C. Yang Y.P. Nicol C.J.B. Wang C.J. Gold nanoparticles in neurological diseases: A review of neuroprotection. Int. J. Mol. Sci. 2024 25 4 2360 10.3390/ijms25042360 38397037
    [Google Scholar]
  234. Mishra J. Kumar B. Pandey M. Pottoo F.H. Fayaz F. Khan F.A. Sahoo P.K. Carbon nano tubes: Novel drug delivery system in amelioration of alzheimer’s disease. Comb. Chem. High Throughput Screen. 2021 24 10 1528 1543 10.2174/1386207323999200918112538 32957874
    [Google Scholar]
  235. Salvo J. Sandoval C. Role of copper nanoparticles in wound healing for chronic wounds: Literature review. Burns Trauma 2022 10 tkab047 10.1093/burnst/tkab047 35071652
    [Google Scholar]
  236. Yang G. Zhang M. Qi B. Zhu Z. Yao J. Yuan X. Sun D. Nanoparticle-based strategies and approaches for the treatment of chronic wounds. J. Biomater. Tissue Eng. 2018 8 4 455 464 10.1166/jbt.2018.1776
    [Google Scholar]
  237. Fadeel B. Keller A.A. Nanosafety: A perspective on nano‐bio interactions. Small 2024 20 28 2310540 10.1002/smll.202310540 38597766
    [Google Scholar]
  238. Bergamaschi E. Poland C. Guseva Canu I. Prina-Mello A. The role of biological monitoring in nano-safety. Nano Today 2015 10 3 274 277 10.1016/j.nantod.2015.02.001
    [Google Scholar]
  239. Pulido-Reyes G. Leganes F. Fernández-Piñas F. Rosal R. Bio-nano interface and environment: A critical review. Environ. Toxicol. Chem. 2017 36 12 3181 3193 10.1002/etc.3924 28731222
    [Google Scholar]
/content/journals/ctmc/10.2174/0115680266362334251024043000
Loading
Transcending Cellular Barriers by Leveraging Nano-Bio Interactions in Nanomaterial-Driven Disease Therapy
Bentham Science Publishers ; https://doi.org/10.2174/0115680266362334251024043000
/content/journals/ctmc/10.2174/0115680266362334251024043000
/content/journals/ctmc/10.2174/0115680266362334251024043000
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: disease therapy ; optimization ; nano-bio interface ; targeted delivery ; Nanomaterials ; cellular barriers

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test